Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |